- Home
- LFVN vs OPTN Comparison
LFVN vs OPTN Comparison
Compare LFVN & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFVN
- OPTN
- Stock Information
- Founded
- LFVN N/A
- OPTN 2010
- Country
- LFVN United States
- OPTN United States
- Employees
- LFVN N/A
- OPTN N/A
- Industry
- LFVN Biotechnology: Pharmaceutical Preparations
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- LFVN Health Care
- OPTN Health Care
- Exchange
- LFVN Nasdaq
- OPTN Nasdaq
- Market Cap
- LFVN 188.1M
- OPTN 78.4M
- IPO Year
- LFVN N/A
- OPTN 2017
- Fundamental
- Price
- LFVN $17.32
- OPTN $0.42
- Analyst Decision
- LFVN Strong Buy
- OPTN Strong Buy
- Analyst Count
- LFVN 1
- OPTN 3
- Target Price
- LFVN $26.00
- OPTN $3.00
- AVG Volume (30 Days)
- LFVN 91.8K
- OPTN 835.9K
- Earning Date
- LFVN 01-28-2025
- OPTN 11-12-2024
- Dividend Yield
- LFVN 0.93%
- OPTN N/A
- EPS Growth
- LFVN 59.77
- OPTN N/A
- EPS
- LFVN 0.32
- OPTN N/A
- Revenue
- LFVN $196,014,000.00
- OPTN $75,672,000.00
- Revenue This Year
- LFVN $4.36
- OPTN $13.42
- Revenue Next Year
- LFVN $3.85
- OPTN $52.99
- P/E Ratio
- LFVN $55.49
- OPTN N/A
- Revenue Growth
- LFVN N/A
- OPTN 5.13
- 52 Week Low
- LFVN $5.22
- OPTN $0.32
- 52 Week High
- LFVN $18.41
- OPTN $2.10
- Technical
- Relative Strength Index (RSI)
- LFVN 66.83
- OPTN 35.42
- Support Level
- LFVN $15.35
- OPTN $0.39
- Resistance Level
- LFVN $18.41
- OPTN $0.57
- Average True Range (ATR)
- LFVN 1.14
- OPTN 0.05
- MACD
- LFVN 0.22
- OPTN -0.00
- Stochastic Oscillator
- LFVN 82.14
- OPTN 16.53
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.